Key result
Intravenous inoculation of a recombination-defective poliovirus variant resulted in significant attenuation of virulence and increased time-to-death compared to wild-type virus (p=2.3x10-6).
p-value: p=2.3x10-6
RNA recombination is essential for poliovirus to overcome host barriers during intra-host spread, explaining its evolutionary maintenance despite replicative fitness costs.
Recombination-defective poliovirus attenuates virulence in animals; leaves open whether recombination inhibition could inform safer vaccines or therapies.
The contribution of RNA recombination to viral fitness and pathogenesis is poorly defined. Here, we isolate a recombination-deficient, poliovirus variant and find that, while recombination is detrimental to virus replication in tissue culture, recombination is important for pathogenesis in infected animals. Notably, recombination-defective virus exhibits severe attenuation following intravenous inoculation that is associated with a significant reduction in population size during intra-host spread. Because the impact of high mutational loads manifests most strongly at small population sizes, our data suggest that the repair of mutagenized genomes is an essential function of recombination and that this function may drive the long-term maintenance of recombination in viral species despite its associated fitness costs. Significance Statement RNA recombination is a widespread but poorly understood feature of RNA virus replication. For poliovirus, recombination is involved in the emergence of neurovirulent circulating vaccine-derived poliovirus, which has hampered global poliovirus eradication efforts. This emergence illustrates the power of recombination to drive major adaptive change; however, it remains unclear if these adaptive events represent the primary role of recombination in virus survival. Here, we identify a viral mutant with a reduced rate of recombination and find that recombination also plays a central role in the spread of virus within animal hosts. These results highlight a novel approach for improving the safety of live attenuated vaccines and further our understanding of the role of recombination in virus pathogenesis and evolution.
No takes yet. Share an insight, caveat, or question.
Acevedo et al. (2018) studied Poliovirus infection (n=102). Recombination-deficient poliovirus (Y275H mutation) vs. Wild type poliovirus was evaluated on Time-to-death following intravenous infection (p=2.3x10-6). Intravenous inoculation of a recombination-defective poliovirus variant resulted in significant attenuation of virulence and increased time-to-death compared to wild-type virus (p=2.3x10-6).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: